Browsing Tag
Shanghai
44 posts
CirCode Biomed’s HM2002 gets FDA green light: World’s first circular RNA drug to enter U.S. clinical trials for heart disease
CirCode’s HM2002 becomes the first circular RNA drug cleared by the FDA for clinical trials in ischemic heart disease—setting a precedent in RNA therapeutics.
CARsgen’s CT0596 CAR-T shows strong early results in refractory myeloma
CARsgen’s allogeneic CAR-T therapy CT0596 shows early safety and efficacy in myeloma—find out how investors are reacting to the 2025 breakthrough.
Why did China’s stock market crash and how did its sovereign wealth fund respond?
Find out how China’s sovereign wealth fund is stepping in to stabilise markets amid a deepening trade war and rising global recession fears.
Merck licenses innovative anti-cancer therapy LM-299 from LaNova Medicines
In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as…
Shanghai crumbles as most powerful typhoon in 75 years brings city to its knees
Shanghai came to a standstill as Typhoon Bebinca, the most powerful storm in 75 years, hit the city…
North Field South Project : QatarEnergy forges new LNG partnership with Sinopec
In a pivotal agreement poised to bolster the LNG industry, QatarEnergy has inked a partnership accord with China…
Shandong earthquake: Tremors disrupt train services, buildings crumble
In a shocking event that left China’s eastern province of Shandong in devastation, a magnitude 5.5 earthquake struck…
Pony.ai, Toyota, and GAC Toyota form driverless robotaxis joint venture
Pony.ai, a Chinese autonomous driving company, Toyota Motor (China) Investment Co., Ltd. (TMCI), and GAC Toyota Motor Co.,…
Viva Biotech sells 24% stake in CRO business Viva Shanghai for $150m
Viva Biotech Holdings Group has announced the fundraising of nearly $150 million by transferring about 24% of its…
CLPS subsidiary JAJI to develop smart cockpit for safer intelligent vehicles
Hong Kong-based CLPS Incorporation has announced that its majority-owned subsidiary, JAJI (Shanghai), has initiated the development of a…